Baclofen IR

DRUG2 trials

Sponsors

Alkermes, Inc., Impax Laboratories, LLC

Conditions

Alcohol DependenceMultiple SclerosisSpasticity

Phase 1

ALK29-002: A Study of Baclofen Formulations in Healthy Adults

CompletedNCT00802035

Alkermes, Inc.Alcohol Dependence

Start: 2008-11-30End: 2009-02-28Updated: 2011-08-23

Phase 2

A Study With IPX056 in Subjects With Spasticity Associated With Multiple Sclerosis

CompletedNCT00914290

Impax Laboratories, LLCMultiple Sclerosis, Spasticity

Start: 2009-04-30End: 2010-02-28Updated: 2019-11-06